Genèse Labs

17

RG Body Filler Line-Up Expanded: RG80, RG100 and RG55S

From a single product to a graduated family for non-surgical body contouring Paris, France — 20 May 2025 — Genèse Labs has added RG80, RG100 and the syringe-type RG55S to its RG Body Filler line. Building on RG60®, the company’s first in-house product launched in 2023, practitioners can now select from four formats according to treatment area and volume.• Launch of RG80 (80 ml), RG100 (100 ml) and RG55S (55 ml s..

2025-05-20

16

Participation in Dubai Derma 2025

Formally entering the Middle East at the region’s largest dermatology congress Dubai, UAE — 14–16 April 2025 — Genèse Labs took part in Dubai Derma 2025 at the Dubai World Trade Centre, formally entering the Middle East and North Africa (MENA) aesthetic market.• Participation in the largest scientific dermatology gathering in the Middle East, North Africa and the Indian Subcontinent• An exhibition featuring more..

2025-04-17

15

Réluma HA Filler and Réluma Kiss Launch with KFDA Approval

Premium French hyaluronic acid meets Hexa-Matrix Crosslinking Technology Paris, France — 8 April 2025 — Genèse Labs has launched Réluma, a facial hyaluronic acid filler line built on high-purity HA from HTL Biotechnology, France, together with the lip-dedicated Réluma Kiss, and has obtained KFDA approval for Réluma.• Hyaluronic acid from HTL Biotechnology, France, a world-leading manufacturer of high-purity HA• ..

2025-04-08

14

Participation in AMWC Monaco 2025

Presenting an expanded portfolio at the world’s leading aesthetic and anti-ageing medicine congress Monte-Carlo, Monaco — 27–29 March 2025 — Genèse Labs took part in the 23rd Aesthetic & Anti-Aging Medicine World Congress (AMWC) at the Grimaldi Forum, presenting its expanded portfolio to practitioners and distribution partners from around the world.• Participation in AMWC Monaco, the leading international congress for..

2025-03-30

13

Proluma™ PLLA Launch and CE Certification

Completing the Proluma™ biostimulator line: PLLA 365 mg for deep structural volume restoration Paris, France — 17 February 2025 — Genèse Labs has launched Proluma™ PLLA 365 mg, an injectable collagen biostimulator, together with CE certification as a Class III medical device — completing a two-formulation Proluma™ line alongside PDLLA 200 mg.• Injectable collagen biostimulator based on poly-L-lactic acid (PLLA) 3..

2025-02-17

12

Participation in AMWC Southeast Asia 2024

Entering the Southeast Asian market through the Bangkok congress Bangkok, Thailand — 21–23 November 2024 — Genèse Labs has taken part in AMWC Southeast Asia 2024 in Bangkok, extending its international congress activity into one of the fastest-growing regions in aesthetic medicine.• Participation in a principal academic and commercial meeting point for Southeast Asian aesthetic medicine• Practitioners from Thailand, Vietn..

2024-11-25

11

Proluma™ Wins Best Aesthetic Product at Cosmoprof Asia 2024

Genèse Labs’ PDLLA collagen stimulator recognised on the global stage Hong Kong — 20 November 2024 — Genèse Labs is pleased to announce that Proluma™, its next-generation PDLLA collagen stimulator, has won in the “Best Aesthetic Product” category at Cosmoprof Asia 2024 in Hong Kong.• “Best Aesthetic Product” award at Cosmoprof Asia 2024, one of the world’s most influential beauty and medical-aesthetics exhibitio..

2024-11-20

10

Participation in Cosmoprof Asia 2024

Presenting the full portfolio at Asia’s largest beauty exhibition Hong Kong — 12–14 November 2024 — Genèse Labs has taken part in Cosmoprof Asia 2024 in Hong Kong, presenting its full portfolio to one of the largest international audiences in the beauty and aesthetics industry.• More than 60,000 international visitors and over 2,500 participating brands• Full portfolio presented across three pillars: regenerative, body co..

2024-11-15

9

Exoluma™ Plant & Human Series Launch and CPNP Registration

Nobel-recognised science in skincare: Exoluma™, a next-generation exosome complex solution Paris, France — 30 October 2024 — Genèse Labs has launched the Exoluma™ Plant & Human series — a dual-vial system combining purified exosomes with regenerative ingredients — together with completion of CPNP registration, closing a year in which the company brought four product families to market.• Dual-vial exosome com..

2024-10-30

8

Participation in AMWC Latin America 2024

First steps into the Latin American aesthetic community Medellín, Colombia — 17–19 October 2024 — Genèse Labs has formally entered the Latin American aesthetic-medicine community with its participation in AMWC Colombia 2024, one of the region’s principal academic congress platforms for practitioners, distributors and manufacturers.• First formal entry into the Latin American aesthetic-medicine community• Body-co..

2024-10-21

7

Citrus Bottle™ Launch and CPNP Registration

Citrus Bottle™: a next-generation slimming solution targeting adipocyte metabolism Paris, France — 22 April 2024 — Genèse Labs has launched Citrus Bottle™, a facial and body slimming solution based on adipocyte-metabolism technology, together with completion of its trademark registration and CPNP registration — extending the company’s portfolio into a new area of body contouring.• A facial and body slimming solu..

2024-04-22

6

Proluma™ PDLLA Launch and CE Certification

Next-generation collagen biostimulator: Proluma™ PDLLA 200 mg Paris, France — 14 February 2024 — Genèse Labs has launched Proluma™ PDLLA, an injectable collagen stimulator built on polymer technology developed at the company’s French headquarters, together with completion of the Proluma™ trademark registration.• Injectable collagen biostimulator based on Poly-D,L-lactic acid (PDLLA) 200 mg• PLA-family materials ..

2024-02-14

검색

We value your privacy